Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Ventricular Tachycardia Storm in Cardiac Sarcoidosis: A 76-Day-ICU-Nightmare.

Naik AM, Patel SB.

Indian Pacing Electrophysiol J. 2012 Nov;12(6):278-83. Epub 2012 Dec 2.

2.

Ventricular tachycardia storm--an atypical presentation of sarcoidosis exacerbation.

Vanga SR, Vacek J, Berenbom L, Lakkireddy DR.

Indian Pacing Electrophysiol J. 2009 Nov 1;9(6):351-4.

3.

Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.

Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, Bogun F.

Heart Rhythm. 2009 Feb;6(2):189-95. doi: 10.1016/j.hrthm.2008.10.039. Epub 2008 Oct 30.

PMID:
19187909
4.

Ventricular tachycardia in cardiac sarcoidosis controlled by radiofrequency catheter ablation.

Bando M, Soeki T, Niki T, Kusunose K, Tomita N, Yamaguchi K, Koshiba K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Sata M.

Intern Med. 2011;50(11):1201-6. Epub 2011 Jun 1.

5.

Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator.

Silva RM, Mont L, Nava S, Rojel U, Matas M, Brugada J.

Pacing Clin Electrophysiol. 2004 Jul;27(7):971-5.

PMID:
15271018
6.

Reinitiation of ventricular macroreentry within the His-Purkinje system by back-up ventricular pacing - a mechanism of ventricular tachycardia storm.

Reithmann C, Hahnefeld A, Oversohl N, Ulbrich M, Remp T, Steinbeck G.

Pacing Clin Electrophysiol. 2007 Feb;30(2):225-35.

PMID:
17338720
7.

Impact of the implantable cardioverter-defibrillator on rehospitalizations.

Valenti R, Schlåpfer J, Fromer M, Fischer A, Kappenberger L.

Eur Heart J. 1996 Oct;17(10):1565-71.

8.

Ventricular tachyarrhythmia as a primary presentation of sarcoidosis.

Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, Pääkkö E, Raatikainen P.

Europace. 2008 Jun;10(6):760-6. doi: 10.1093/europace/eun110. Epub 2008 May 2.

10.

Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.

Teo WS, Kam R, Tan A.

Ann Acad Med Singapore. 1998 Mar;27(2):248-54. Review.

PMID:
9663319
11.

Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.

Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.

PMID:
21955243
12.

[Wide QRS complex tachycardia in a patient with ischemic cardiomyopathy and prior ventricular tachycardia ablation].

Muntean BG, Roser M, Suhail S, Nagel P, Bellmann B.

Herzschrittmacherther Elektrophysiol. 2015 Dec;26(4):367-70. doi: 10.1007/s00399-015-0392-4. Epub 2015 Aug 25. German.

PMID:
26350100
13.

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P.

Circulation. 2008 Jan 29;117(4):462-9. doi: 10.1161/CIRCULATIONAHA.106.686534. Epub 2008 Jan 2.

14.

Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade.

Kantharia BK, Patel JA, Nagra BS, Ledley GS.

Europace. 2006 Aug;8(8):625-8. Epub 2006 Jun 13.

15.

[Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].

Przybylski A, Derejko P, Iwanek M, Urbanek P, Kepski R, Grzybowski J, Chojnowska L, Szumowski Ł, Szwed H, Walczak F.

Kardiol Pol. 2006 Jul;64(7):758-62. Polish.

16.

Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.

Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, Cooper JM.

Heart Rhythm. 2012 Jun;9(6):884-91. doi: 10.1016/j.hrthm.2012.02.010. Epub 2012 Feb 13.

PMID:
22338670
17.

Implantable transvenous cardioverter-defibrillators.

Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.

Circulation. 1993 Apr;87(4):1152-68.

PMID:
8462144
19.

Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.

Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M.

Circulation. 1995 Sep 1;92(5):1159-68.

20.

A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator.

Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Hasse C, Bogun F, Knight BP, Weiss R, Bahu M, Morady F.

Circulation. 1997 Sep 2;96(5):1525-31.

Items per page

Supplemental Content

Write to the Help Desk